< Back to previous page


Single domain antibodies that neutralize SARS-CoV-2 (01C02620)

The aim of this project is to isolate single domain antibodies that are directed against the receptor-binding domain that is part of the spike protein of SARS-CoV-2. Those single-domain antibodies, separately and combined, will be evaluated for their capacity to neutralize SARS-CoV-2.

Date:15 Apr 2020  →  Today
Keywords:Coronavirus, virus neutralization, antibody
Disciplines:Infectious diseases, Virology, Medical molecular engineering of nucleic acids and proteins